Meeting of the National Vaccine Advisory Committee, 24044 [05-9018]

Download as PDF 24044 Federal Register / Vol. 70, No. 87 / Friday, May 6, 2005 / Notices Office of Management and Budget (OMB) a request to review and approve a renewal of a currently approved information collection requirement regarding the GSAR Price Reductions Clause. A request for public comments was published at 70 FR 10404, March 3, 2005. No comments were received. Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected. Submit comments on or before: June 6, 2005. DATES: Ms. Linda Nelson, Procurement Analyst, Contract Policy Division, at telephone (202) 501–1900 or via e-mail to linda.nelson@gsa.gov. FOR FURTHER INFORMATION CONTACT: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Ms. Jeanette Thornton, GSA Desk Officer, OMB, Room 10236, NEOB, Washington, DC 20503, and a copy to the Regulatory Secretariat (VIR), General Services Administration, Room 4035, 1800 F Street, NW., Washington, DC 20405. Please cite OMB Control No. 3090–0235, Price Reductions Clause, in all correspondence. ADDRESSES: SUPPLEMENTARY INFORMATION: A. Purpose The clause at GSAR 552.238–75, Price Reductions, used in multiple award schedule contracts ensures that the Government maintains its relationship with the contractor’s customer or category of customers, upon which the contract is predicated. B. Annual Reporting Burden Number of Respondents: 16,680. Total Annual Responses: 33,360. Average hours per response: 7.5 hours. Total Burden Hours: 250,200. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VIR), 1800 F Street, NW., Room 4035, Washington, DC 20405, telephone (202) 208–7312. Please cite OMB Control No. 3090–0235, Price Reductions Clause, in all correspondence. VerDate jul<14>2003 19:51 May 05, 2005 Jkt 205001 Dated: April 29, 2005 Julia Wise, Director,Contract Policy Division [FR Doc. 05–9100 Filed 5–5–05; 8:45 am] BILLING CODE 6820–61–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary. ACTION: Notice. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (DHHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. DATES: The meeting will be held on June 7, 2005, from 9 a.m. to 5 p.m., and on June 8, 2005, from 9 a.m. to 3:30 p.m. ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, National Vaccine Program Office, Department of Health and Human Services, Room 433–H Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; (202) 690–5566, nvac@osophs.dhhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Service Act (42 U.S.C. Section 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Assistant Secretary for Health, as the Director of the National Vaccine Program, on matters related to the program’s responsibilities. Topics to be discussed at the meeting include vaccine supply, adolescent immunization, influenza, and pandemic influenza preparedness. New members will be welcomed to the Committee and updates will be given by various subcommittees and working groups. A tentative agenda will be made available on or about May 15, 2005, for review on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac. Public attendance at the meeting is limited to space available. Individuals PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 must provide a photo ID for entry into the Humphrey Building. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed material distributed to NVAC members should submit materials to the Executive Secretary, NVAC, through the contact person listed above prior to close of business May 31, 2005. Preregistration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should e-mail nvac@osophs.dhhs.gov. Dated: May 2, 2005. Bruce Gellin, Director, National Vaccine Program Office. [FR Doc. 05–9018 Filed 5–5–05; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–05–05CA] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–371–5983 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

[Federal Register Volume 70, Number 87 (Friday, May 6, 2005)]
[Notices]
[Page 24044]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9018]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on June 7, 2005, from 9 a.m. to 5 p.m., 
and on June 8, 2005, from 9 a.m. to 3:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 433-H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, 
nvac@osophs.dhhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Assistant 
Secretary for Health, as the Director of the National Vaccine Program, 
on matters related to the program's responsibilities.
    Topics to be discussed at the meeting include vaccine supply, 
adolescent immunization, influenza, and pandemic influenza 
preparedness. New members will be welcomed to the Committee and updates 
will be given by various subcommittees and working groups. A tentative 
agenda will be made available on or about May 15, 2005, for review on 
the NVAC Web site: https://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business May 31, 2005. Preregistration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should e-mail 
nvac@osophs.dhhs.gov.

    Dated: May 2, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-9018 Filed 5-5-05; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.